PEG-it Virus Precipitation Solution
Home | Exploiting an Asp-Glu “switch” in glycogen synthase kinase 3 to design paralog-selective inhibitors for use in acute myeloid leukemia
Wagner, FF, et al. (2018) Exploiting an Asp-Glu “switch” in glycogen synthase kinase 3 to design paralog-selective inhibitors for use in acute myeloid leukemia. Sci Transl Med. 2018 Mar 7; 10(431). PM ID: 29515000
System Biosciences, LLC
2438 Embarcadero Way
Palo Alto, CA 94303
Toll free: (888) 266-5066
Direct: (650) 968-2200
Fax: (650) 968-2277
© 2018 System Biosciences, LLC. All Rights Reserved. TERMS AND CONDITIONS OF SALE | PRIVACY STATEMENT